Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Giant Cell Tumor of Tendon Sheath

• Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor
• Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
• Study of Vimseltinib for Tenosynovial Giant Cell Tumor
• A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
• Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
• A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
• Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
• A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
• Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
• Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
• MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)
• Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)
• Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor